New sensor aims to help doctors see inside arteries during procedures

NCT ID NCT06112054

Completed Knowledge-focused Sponsor: Sensome Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested a special guidewire with a sensor that measures electrical properties of tissues in people with peripheral artery disease. The goal was to see if the sensor could tell the difference between various tissues, like the artery wall and surrounding areas. Nineteen participants were included, and the study focused on whether the device could successfully take these measurements during standard procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Clotild Smart Guidewire System (CSGS) - a device with an impedance sensor
What this could lead to: If successful, this sensor could help doctors better identify different tissues during artery procedures, potentially improving treatment accuracy.
What could go wrong: This was a very small, early feasibility study with only 19 participants. It only tested if the sensor could take measurements, not if it improves patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

peripheral arterial disease peripheral vascular disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIPHERAL VASCULAR DISEASE

Contacts and locations

Locations

AZ Sint Blasius

Dendermonde, 9200, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.